Corcept Therapeutics reported $36.95M in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Ardelyx ARDX:US $ -27.58M 4.9M
Aurora Cannabis Inc ACB:CN -88561000 17.03M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Canopy Growth Corp WEED:CN C$ -273741000 191.85M
Corcept Therapeutics CORT:US $ 36.95M 0.45M
Esperion Therapeutics ESPR:US $ -42836000 611K
Lexicon Pharmaceuticals LXRX:US $ -23.27M 1.95M
Merk MRK:US $ 6179M 492M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Novartis NOVN:VX SF 4552M 346M
Novartis NVS:US $ 4552M 346M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
Ziopharm Oncology ZIOP:US $ -8.4M 1.21M